· Insider activity · ABBV

AbbVie Inc (ABBV) director adds stock-equivalent units after 25.5% 12-week rise

The insider acquisition lands with the biopharma stock still in an active weekly trend, though latest volume ran below its 13-week average.

Biopharmaceutical laboratory and market-data screen representing AbbVie insider activity and weekly stock context.

AbbVie Inc (ABBV) recorded insider activity dated June 30, when Director Edward J. Rapp acquired 134 stock equivalent units at 251.64 USD per unit.

Weekly market data show the shares last closed at 259.36 USD, with a 1.9% one-week gain and a 3.1% four-week advance. The 52-week weekly price path remains constructive, supported by active trend status, Market Dynamics confirmation at 1.16, and Relative Strength of 9.3, while volume at 0.69 times the 13-week average tempers the signal.